Role of inflammation in pancreatic carcinogenesis and the implications for future therapy

Devesa, 1995, Recent cancer trends in the United States, J Natl Cancer Inst, 87, 175, 10.1093/jnci/87.3.175 Duffy, 2003, Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer, Molec Cancer, 2, 12, 10.1186/1476-4598-2-12 Warshaw, 1990, Preoperative staging and assessment of resectability of pancreatic cancer, Archs Surg, 125, 230, 10.1001/archsurg.1990.01410140108018 Rohan, 1981, Alimentary tract cancer mortality in Australia, 1908–1978. An epidemiological appraisal, Med J Aust, 1, 232, 10.5694/j.1326-5377.1981.tb135509.x Imaizumi, 1996, Longitudinal Gompertzian analysis of mortality from pancreatic cancer in Japan, 1955-1993, Mech Ageing Dev, 90, 163, 10.1016/0047-6374(96)01760-5 Levi, 1988, Trends in cancer mortality in Switzerland, 1951-1984, Rev Epidemiol Santé Publ, 36, 15 Lilliemoe, 2000, Pancreatic cancer: state-of-the-art care, Can Cancer J Clin, 50, 241, 10.3322/canjclin.50.4.241 Boyle, 1996, Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARC, Int J Cancer, 67, 63, 10.1002/(SICI)1097-0215(19960703)67:1<63::AID-IJC12>3.0.CO;2-D Weiderpass, 2003, Occupational exposures and gastrointestinal cancers among Finnish women, J Occup Environ Med, 45, 305, 10.1097/01.jom.0000052963.43131.44 Garabant, 1992, DDT and related compounds and risk of pancreatic cancer, J Natl Cancer Inst, 84, 764, 10.1093/jnci/84.10.764 Anttila, 1995, Cancer incidence among Finnish workers exposed to halogenated hydrocarbons, J Occup Environ Med, 37, 797, 10.1097/00043764-199507000-00008 Anderson, 2002, Meat intake and cooking techniques: associations with pancreatic cancer, Mutat Res, 30, 225, 10.1016/S0027-5107(02)00169-0 Tersmette, 2001, Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer, Clin Cancer Res, 7, 738 Ghadrian, 2002, Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas, Int J Cancer, 97, 807, 10.1002/ijc.10123 Hruban, 2001, Prevention of pancreatic cancer and strategies for management of pancreatic cancer, Dig Dis, 19, 76, 10.1159/000050656 Raderer, 1998, Association between Helicobacter pylori infection and pancreatic cancer, Oncology, 55, 16, 10.1159/000011830 Rocca, 1987, Increased incidence of cancer in chronic pancreatitis, Jf Clin Gastroenterol, 9, 175, 10.1097/00004836-198704000-00013 Otsuki, 2003, Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems, J Gastroenterol, 38, 315, 10.1007/s005350300058 Maisonnneuve, 2002, Chronic pancreatitis and pancreatic cancer, Dig Dis, 20, 32, 10.1159/000063165 Bansal, 1995, Chronic pancreatitis is a risk factor for pancreatic cancer, Gastroenterology, 109, 247, 10.1016/0016-5085(95)90291-0 Ekbom, 1994, Pancreatitis and pancreatic cancer: a population based study, J Natn Cancer Inst, 86, 625, 10.1093/jnci/86.8.625 Talamini, 1999, Incidence of cancer in the course of chronic pancreatitis, Am J Gastroenterol, 94, 1253, 10.1111/j.1572-0241.1999.01075.x Lowenfels, 1993, Pancreatitis and the risk of pancreatic cancer, N Engl J Med, 328, 1433, 10.1056/NEJM199305203282001 Lowenfels, 1997, Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group, J Natn Cancer Inst, 90, 442, 10.1093/jnci/89.6.442 Whitcomb, 1999, Hereditary pancreatitis and the risk of pancreatic carcinoma, Ann NY Acad Sci, 880, 1433, 10.1111/j.1749-6632.1999.tb09524.x Ammann, 1980, High incidence of extrapancreatic carcinoma in patients with chronic pancreatitis, Scand J Gastroenterol, 15, 395, 10.3109/00365528009181490 Talamini, 1996, Cigarette smoking: an independent risk factor in alcoholic pancreatitis, Pancreas, 12, 131, 10.1097/00006676-199603000-00004 Queneau, 2001, Early detection of pancreatic cancer in patients with chronic pancreatitis; diagnostic utility of a K-ras point mutation in the pancreatic juice, Am J Gastroenterol, 96, 700, 10.1111/j.1572-0241.2001.03608.x Mulligan, 1999, The role of p21 ras in pancreatic neoplasia and chronic pancreatitis, Hum Pathol, 30, 602, 10.1016/S0046-8177(99)90082-5 Van Laethem, 1998, Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases, Gastrointest Endosc, 47, 479, 10.1016/S0016-5107(98)70248-2 Schlosser, 2002, Cyclooxygen-ase-2 is overexpressed in chronic pancreatitis, Pancreas, 25, 26, 10.1097/00006676-200207000-00008 Basso, 1994, Lipid peroxidation and renal tubular damage in chronic pancreatic diseases: is there any relationship, J Med, 25, 91 Basso, 1990, Oxygen derived free radicals in patients with chronic pancreatitis and other digestive diseases, J Clin Pathol, 43, 403, 10.1136/jcp.43.5.403 Niu, 2004, Identification of an autoregulatory feedback pathway involving interleukin-1 alpha in induction of NF-KB activation in pancreatic cancer cells, J Biol Chem, 279, 16452, 10.1074/jbc.M309789200 Baldwin, 1996, The NF-kappaB and I kappaB proteins: new discoveries and insights, Ann Rev Immunol, 14, 649, 10.1146/annurev.immunol.14.1.649 Yamamoto, 2001, Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer, J Clin Invest, 107, 7, 10.1172/JCI11914 Shi, 1999, Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia, J Interferon Cytokine Res, 19, 1363, 10.1089/107999099312821 Chandler, 2004, Increased expression of NF-KB subunits in human pancreatic cancer cells, J Surg Res, 118, 9, 10.1016/S0022-4804(03)00354-8 Liptay, 2003, Mitogenic and antiapoptotic role of constitutive NF-KB/Rel activity in pancreatic cancer, Int J Cancer, 105, 735, 10.1002/ijc.11081 Wang, 1999, The nuclear factor-KB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells, Clin Cancer Res, 5, 119 Fujioka, 2003, Function of nuclear factor kappaB in pancreatic cancer metastases, Clin Cancer Res, 9, 345 Greten, 2002, Stat3 and NF-kB activation prevents apoptosis in pancreatic carcinogenesis, Gastroenterology, 123, 2052, 10.1053/gast.2002.37075 Chang, 2003, Nuclear factor kB protects pancreatic beta-cells from tumour necrosis factor-alpha mediated apoptosis, Diabetes, 52, 1169, 10.2337/diabetes.52.5.1169 Algul, 2002, NF-KappaB/Rel transcription pathway: implications in pancreatic cancer, Int J Gastrointest Cancer, 31, 71, 10.1385/IJGC:31:1-3:71 Trauzold, 2001, CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-KB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells, Oncogene, 20, 4258, 10.1038/sj.onc.1204559 Gross, 1999, BCL-2 family members and the mitochondria in apoptosis, Genes Dev, 13, 1899, 10.1101/gad.13.15.1899 Schmid, 2000, NF-kappaB/Rel/Ikap-paB: implications in gastrointestinal diseases, Gastroenterology, 118, 1208, 10.1016/S0016-5085(00)70374-X Kornmann, 1998, Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival, Oncology, 55, 363, 10.1159/000011879 Shi, 2000, Regulation of interleukin-8 expression by cellular pH in human pancreatic adenocarcinoma cells, J Interferon Cytokine Res, 20, 1023, 10.1089/10799900050198471 Xiong, 2004, NF-KB activity blockade impairs the angiogenic potential of human pancreatic cancer cells, Int J Cancer, 108, 181, 10.1002/ijc.11562 Brew, 1997, Interleukin-8 as a growth factor for human colorectal carcinoma cells in vitro, Biochem Soc Trans, 25, 246S, 10.1042/bst025264s Brew, 2000, Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro, Cytokine, 12, 78, 10.1006/cyto.1999.0518 Takeda, 2002, Role of angiogenesis in the development and growth of liver metastasis, Ann Surg Oncol, 9, 610, 10.1007/BF02574475 Kuwada, 2003, Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells, Int J Oncol, 22, 765 Yebra, 1995, Induction of carcinoma cell migration on vitronectin by NF-kB-dependent gene expression, Mol Biol Cell, 6, 841, 10.1091/mbc.6.7.841 Fahy, 2004, Inhibition of AKT abrogates chemotherapy-induced NF-KB survival mechanisms: implications for therapy in pancreatic cancer, J Am Coll Surg, 198, 591, 10.1016/j.jamcollsurg.2003.12.005 Arlt, 2003, Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death, Oncogene, 22, 3243, 10.1038/sj.onc.1206390 Fujioka, 2003, Inhibition of constitutive NF-kB activity by IkB-alpha-M suppresses tumorigenesis, Oncogene, 22, 1365, 10.1038/sj.onc.1206323 Arlt, 2001, Inhibition of NF-KB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin, Oncogene, 20, 859, 10.1038/sj.onc.1204168 Thomas, 2002, Selective targeting of the nuclear factor-kappaB pathway enhances tumour necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death, Surgery, 132, 127, 10.1067/msy.2002.124930 Nagasaki, 2003, Leucine-zipper protein, LDOC1, inhibits NF-KappaB activation and sensitizes pancreatic cancer cells to apoptosis, Int J Cancer, 105, 454, 10.1002/ijc.11122 Muerkoster, 2003, Usage of the NF-KappaB inhibitor sulphasalazine as a sensitizing agent in combined chemotherapy of pancreatic cancer, Int J Cancer, 104, 469, 10.1002/ijc.10963 McDade, 1999, Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells, J Surg Res, 83, 56, 10.1006/jsre.1998.5560 Blanchard, 2001, Antioxidants inhibit cytokine production and suppress NF-kappaB activation in CAPAN-1 and CAPAN-2 cell lines, Dig Dis Sci, 46, 2768, 10.1023/A:1012795900871 Mouria, 2002, Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis, Int J Cancer, 98, 761, 10.1002/ijc.10202 Plummer, 1999, Inhibition of cyclooxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex, Oncogene, 18, 6013, 10.1038/sj.onc.1202980 Prescott, 2000, Cyclooxygenase-2 and carcinogenesis, Biochim Biophys Acta, 1470, M69 Williams, 1999, The role of cyclooxygenases in inflammation, cancer and development, Oncogene, 18, 7908, 10.1038/sj.onc.1203286 Eberhart, 1994, Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 107, 1183, 10.1016/0016-5085(94)90246-1 Molina, 1999, Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti inflammatory drugs, Cancer Res, 59, 4356 Yip-Schneider, 2000, Cyclooxygenase-2 expression in human pancreatic cancer adenocarcinomas, Carcinogenesis, 21, 139, 10.1093/carcin/21.2.139 Kokawa, 2001, Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors, Cancer, 91, 333, 10.1002/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N Kong, 2002, Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer, J Gastroenterol Hepatol, 17, 914, 10.1046/j.1440-1746.2002.02829.x Tucker, 1999, Cyclooxygenase-2 is up-regulated in human pancreatic cancer, Cancer Res, 59, 987 Niijima, 2002, Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumours of the pancreas, Cancer, 94, 1565, 10.1002/cncr.10358 Koshiba, 1999, Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumours, Int J Pancreatol, 26, 69, 10.1007/BF02781733 Okami, 1999, Overexpression of cyclooxygenase-2 in carcinoma of the pancreas, Clin Cancer Res, 5, 2018 Merati, 2001, Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters, Am J Clin Oncol, 24, 447, 10.1097/00000421-200110000-00007 Maitra, 2002, Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging, Am J Clin Pathol, 118, 194, 10.1309/TPG4-CK1C-9V8V-8AWC Ohike, 2001, Immunohistochemical analysis of cyclooxygenase (COX)-2 expression in pancreatic endocrine tumours: association with tumour progression and proliferation, Pathol Int, 51, 770, 10.1046/j.1440-1827.2001.01273.x Okami, 2002, An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumours of the pancreas, J Exp Clin Cancer Res, 21, 569 Aoki, 2002, Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumours, Oncol Rep, 9, 761 Ding, 2000, Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells, Anticancer Res, 20, 2625 Eibl, 2003, PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells, Biochem Biophys Res Commun, 306, 887, 10.1016/S0006-291X(03)01079-9 Chu, 2003, Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumour-associated angiogenesis and growth of pancreatic cancer, Mol Cancer Ther, 2, 1, 10.1186/1476-4598-2-1 Yip-Schneider, 2001, Cell cycle effects of non-steroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells, J Pharmacol Exp Ther, 298, 976 Okami, 2003, Suppression of pancreatic cancer cell invasion by a cyclo-oxygenase-2-specific inhibitor, Clin Exp Metastasis, 20, 577, 10.1023/A:1027319903359 Furukawa, 2003, A cyclooxygenase-2 inhibitor, nimesulide, inhibits post initiation phase of N-nitrosobic(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters, Int J Cancer, 104, 269, 10.1002/ijc.10965 Wenger, 2002, Effects of Celebrex and Zyflo on BOP-induced pancreatic cancer in Syrian hamsters, Pancreatology, 2, 54, 10.1159/000049449 Tseng, 2002, Selective cyclooxygenase-2 inhibitor rofecoxib (VIOXX) induces expression of cell cycle arrest genes and slows tumour growth in pancreatic cancer, J Gastrointest Surg, 6, 838, 10.1016/S1091-255X(02)00061-6 Wei, 2004, Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity, Cancer Res, 64, 2030, 10.1158/0008-5472.CAN-03-1945 Wenger, 2002, Effects of Celebrex and Zyflo on liver metastasis and lipid peroxidation in pancreatic cancer in Syrian hamsters, Clin Exp Metastasis, 19, 681, 10.1023/A:1021387826867 Rich, 2003, COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: oesophagus, stomach and pancreas, Am J Clin Oncol, 26, S110, 10.1097/01.COC.0000074148.37768.3E Crane, 2003, Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer, Am J Clin Oncol, 26, S81, 10.1097/00000421-200308002-00009 Anderson, 2002, Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer, J Natl Cancer Inst, 94, 1168, 10.1093/jnci/94.15.1168 Jacobs, 2004, Aspirin use and pancreatic cancer mortality in a large United States cohort, J Natl Cancer Inst, 96, 524, 10.1093/jnci/djh084 Menezes, 2002, Regular use of aspirin and pancreatic cancer risk, Biomed Central Publ Health, 2, 18, 10.1186/1471-2458-2-18 Schernhammer, 2003, A prospective study of aspirin use and the risk of pancreatic cancer in women, J Natl Cancer Inst, 96, 22, 10.1093/jnci/djh001 Ding, 2003, Lipoxygenase and cyclooxygenase metabolism: new insights in the treatment and prevention of pancreatic cancer, Mol Cancer, 2, 10, 10.1186/1476-4598-2-10 Ghosh, 1999, Central role of arachidonate 5-lipoxygenase in the regulation of cell growth and apoptosis in human prostate cancer cells, Adv Exp Med Biol, 469, 577, 10.1007/978-1-4615-4793-8_84 Gunning, 2002, Chemoprevention by lipoxygenase and leukotriene pathway inhibitors of vinyl carbamate-induced lung tumours in mice, Cancer Res, 62, 4199 Steele, 1999, Lipoxygenase inhibitors as potential cancer chemopreventives, Cancer Epidemiol Biomarkers Prev, 8, 467 Nie, 2001, Role of eicosanoids in prostate cancer progression, Cancer Metastasis Rev, 20, 195, 10.1023/A:1015579209850 Tang, 1997, Apoptosis of W256 carcinosarcoma cells of the monocytoid origin induced by BDGA involves lipid peroxidation and depletion of GSH: role of 12-lipoxygenase in regulating tumour cell survival, J Cell Physiol, 172, 155, 10.1002/(SICI)1097-4652(199708)172:2<155::AID-JCP3>3.0.CO;2-N Shureiqi, 2000, 15-Lipoxygenase-I mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells, Cancer Res, 60, 6846 Hennig, 2002, 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue, Am J Pathol, 161, 421, 10.1016/S0002-9440(10)64198-3 Tong, 2002, Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway, Mol Cancer Ther, 1, 929 Ding, 1999, Lipoxygenase inhibition induced apoptosis, morphological changes and carbonic anhydrase expression in human pancreatic cancer cells, Biochem Biophys Res Commun, 266, 392, 10.1006/bbrc.1999.1824 Ding, 1999, Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells, Biochem Biophys Res Commun, 261, 218, 10.1006/bbrc.1999.1012 Jenkins, 1995, Roles of nitric oxide in tumour growth, Proc Natl Acad Sci USA, 92, 4392, 10.1073/pnas.92.10.4392 Wu, 1995, Inducible isoforms of cyclooxygenase and nitric oxide synthase, Adv Pharmacol, 33, 179, 10.1016/S1054-3589(08)60669-9 Cui, 1994, Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or independent mechanisms, Cancer Res, 54, 2462 Salvemini, 1993, Nitric oxide activates cyclooxygenase enzymes, Proc Natl Acad Sci USA, 90, 7240, 10.1073/pnas.90.15.7240 Salvemini, 1995, Regulation of prostaglandin production by nitric oxide; an in vivo analysis, Br J Pharmacol, 114, 1171, 10.1111/j.1476-5381.1995.tb13330.x Xiang, 2001, Regulation of IL-8 expression by nitric oxide in human pancreatic adenocarcinoma, J Interferon Cytokine Res, 21, 529, 10.1089/10799900152434411 Xie, 1997, Destruction of bystander cells by tumour cells transfected with inducible nitric oxide (NO) synthase gene, J Natl Cancer Inst, 89, 421, 10.1093/jnci/89.6.421 Morris, 1994, New insights into the regulation of inducible nitric oxide synthesis, Am J Physiol, 266, E829 Gansuage, 1998, Nitric oxideinduced apoptosis in human pancreatic carcinoma cell lines is associated with a G1 arrest and an increase of the cyclin-dependent inhibitor p21WAF1/C1D1, Cell Growth Differentiation, 9, 611 Wang, 2003, A novel model system for studying the double edge roles of nitric oxide production in pancreatic cancer growth and metastasis, Oncogene, 22, 1771, 10.1038/sj.onc.1206386 Franco, 2004, Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic cancer, Prostaglandins Other Lipid Mediators, 73, 51, 10.1016/j.prostaglandins.2003.12.001 Vickers, 1999, Association of increased immunostaining for inducible nitric oxide synthase and nitro tyrosine with fibroblast growth factor transformation in pancreatic cancer, Archs Surg, 134, 245, 10.1001/archsurg.134.3.245 Kong, 2001, Inducible nitric oxide synthase (iNOS) immunoreactivity and its relationship to cell proliferation, apoptosis, angiogenesis, clinicopathological characteristics, and patient survival in pancreatic cancer, Int J Pancreatol, 29, 133, 10.1385/IJGC:29:3:133 Hajri, 1998, Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies, Br J Cancer, 78, 841, 10.1038/bjc.1998.591 Kashfi, 2002, Nitric oxidedonating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue typeindependent effect, J Pharmacol Exp Ther, 303, 1273, 10.1124/jpet.102.042754 Williams, 2001, Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDS) alter the kinetics of human colon cancer cell lines more effectively than traditional NSAIDS: implications for colon cancer chemoprevention, Cancer Res, 61, 3285 Muerkoster, 2004, Tumour stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1 beta, Cancer Res, 64, 1331, 10.1158/0008-5472.CAN-03-1860 Van Antwerp, 1996, Suppression of TNF-alpha-induced apoptosis by NF-kappaB, Science, 274, 787, 10.1126/science.274.5288.787 Wang, 1996, TNF and cancer-therapy induced apoptosis; potentiation by inhibition of NF-kappaB, Science, 274, 784, 10.1126/science.274.5288.784 Beg, 1996, An essential role for NF-kappaB in preventing TNF-alpha-induced cell death, Science, 274, 782, 10.1126/science.274.5288.782 Arlt, 2002, Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines, Cancer Res, 62, 910 Wigmore, 1997, Changes in nutritional status associated with unresectable pancreatic cancer, Br J Cancer, 75, 106, 10.1038/bjc.1997.17 Mahoney, 1988, Induction of weight loss and metabolic alterations by metabolic alterations by human recombinant tumour necrosis factor, Br J Cancer, 58, 345, 10.1038/bjc.1988.216 Hellerstein, 1989, Interleukin-1-induced anorexia in the rate. Influence of prostaglandins, J Clin Invest, 84, 228, 10.1172/JCI114145 Gelin, 1991, Role of endogenous tumour necrosis factor alpha and interleukin 1 for experimental tumour growth and the development of cancer cachexia, Cancer Res, 51, 415 Wigmore, 2002, Cytokine regulation of constitutive production of interleukin -8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer, Int J Oncol, 21, 881 Barber, 1999, Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase response in advanced pancreatic cancer, Clin Sci, 96, 83, 10.1042/CS19980185 Barber, 2000, A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer, Br J Cancer, 83, 1443, 10.1054/bjoc.2000.1479 Matsushima, 1989, Interleukin 8 and MCAF; novel inflammatory cytokines inducible by interleukin 1 and TNF, Cytokine, 1, 2, 10.1016/1043-4666(89)91043-0 Hebert, 1993, Interleukin-8: a review, Cancer Invest, 11, 743, 10.3109/07357909309046949 Mukaida, 1994, Molecular mechanism of interleukin-8 expression, J Leuk Biol, 56, 554, 10.1002/jlb.56.5.554 Fiedler, 1998, Inhibition of TNF-alpha-induced NF-kappaB activation and IL-8 release in A549 cells with the proteasome inhibitor MG-132, Am J Resp Cell Biol, 19, 259, 10.1165/ajrcmb.19.2.3149 Ott, 1998, Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors, J Immunol, 160, 2872, 10.4049/jimmunol.160.6.2872 Galffy, 1999, Interleu-kin 8: an autocrine growth factor for malignant mesothelioma, Cancer Res, 59, 367 Schadendorf, 1993, IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor, J Immunol, 15, 1132 Miller, 1998, Expression of interleukin-8 receptors on tumour cells and vascular endothelial cells in human breast cancer tissue, Anticancer Res, 18, 7781 Yoneda, 1998, Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice, J Natl Cancer Inst, 90, 447, 10.1093/jnci/90.6.447 Haraguchi, 2002, Elevated IL-8 levels in the drainage vein of resectable Dukes C colorectal cancer indicate high risk for developing hepatic metastasis, Oncol Rep, 9, 159 Kitadai, 1998, Transfection of interlukin-8 increases angiogenesis and tumourigenesis of human gastric carcinoma cells in nude mice, Br J Cancer, 81, 647, 10.1038/sj.bjc.6690742 Kitadai, 1998, Expression of interleukin-8 correlates with vascularity in human gastric carcinomas, Am J Pathol, 152, 93 Kido, 2001, Interleukin 8 and vascular endothelial growth factor: prognostic factors in human gastric carcinomas?, Eur J Cancer, 37, 1482, 10.1016/S0959-8049(01)00147-2 Le, 2000, Molecular regulation of constitutive expression of interleukin-8 expression in human pancreatic adenocarcinoma, J Interferon Cytokine Res, 20, 935, 10.1089/10799900050198372 Takamori, 2000, Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1, Pancreas, 21, 52, 10.1097/00006676-200007000-00051 Miyamoto, 1998, Effect of interleukin-8 on production of tumour-associated substances and autocrine growth of human liver and pancreatic cancer cells, Cancer Immunol Immunother, 47, 47, 10.1007/s002620050503 Matsuo, 2003, Enhanced angiogenesis due to inflammatory cytokine from pancreatic cancer cell lines and relation to metastatic potential, Pancreas, 28, 344, 10.1097/00006676-200404000-00025 Shi, 1999, Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic, Clin Cancer Res, 5, 3711 Hidaka, 2002, Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface, Cancer, 95, 1206, 10.1002/cncr.10812 Yoshida, 2000, Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15, Cancer Gene Ther, 7, 324, 10.1038/sj.cgt.7700118 Yano, 2001, Vaccination effect of interleukin-6-producing pancreatic cancer cells in nude mice: a model of tumor prevention and treatment in immune-compromised patients, Jpn J Cancer Res, 92, 83, 10.1111/j.1349-7006.2001.tb01051.x Vacquero, 2004, Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells, J Biol Chem, 23, 243 Marnett, 1999, Lipid peroxidation- DNA damage by malondialdehyde, Mutat Res, 424, 83, 10.1016/S0027-5107(99)00010-X Esterbauer, 1990, Possible mutagens derived from lipids and lipid precursors, Mutat Res Rev Gen Toxicol, 238, 223, 10.1016/0165-1110(90)90014-3 Ames, 1989, Endogenous DNA damage as related to cancer and ageing, Mutation Res, 214, 41, 10.1016/0027-5107(89)90196-6 Hussain, 1998, Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumour suppressor genes, Cancer Res, 58, 4023 Irani, 1997, Mitogenic signalling mediated by oxidants in Ras-transformed fibroblasts, Science, 275, 1649, 10.1126/science.275.5306.1649 Brar, 2003, NOX 5 NAD(P)H oxidase regulates growth and apoptosis in DU145 prostate cancer cells, Am J Physiol Cell Physiol, 285, C353, 10.1152/ajpcell.00525.2002 Lin, 1999, Decreased intracellular superoxide levels actuate SnDB5 virus-induced apoptosis, J Biol Chem, 274, 13650, 10.1074/jbc.274.19.13650 Lindahl, 1993, Instability and decay of the primary structure of DNA, Science, 362, 709 Slupphaug, 2003, The interacting pathways for prevention and repair of oxidative DNA damage, Mutat Res, 531, 231, 10.1016/j.mrfmmm.2003.06.002 Thomas, 2002, The role of oxygen-derived free radical and nitric oxide in cytokine-induced antiproliferation of pancreatic cancer cells, Pancreas, 24, 161, 10.1097/00006676-200203000-00007 Islam, 1997, TGF-beta1 triggers oxidative modifications and enhances apoptosis in hit cells through accumulation of reactive oxygen species by suppression of catalase and glutathione peroxidase, Free Rad Biol Med, 22, 1007, 10.1016/S0891-5849(96)00493-5 Schoenberg, 1995, Oxidative stress in acute and chronic pancreatitis, Am J Clin Nutr, 62, 1306S, 10.1093/ajcn/62.6.1306S Thompson, 1999, Comparison of DNA adduct levels associated with exogenous and endogenous exposures in human pancreas in relation to metabolic genotype, Mutat Res, 424, 263, 10.1016/S0027-5107(99)00024-X Kadlubar, 1998, Comparison of DNA adduct levels associated with oxidative stress in human pancreas, Mutat Res, 405, 124, 10.1016/S0027-5107(98)00129-8 Li, 2002, DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer, Mutat Res, 513, 37, 10.1016/S1383-5718(01)00291-1 Wang, 1998, DNA adducts in human pancreatic tissues and their potential in carcinogenesis, Cancer Res, 58, 38 Weydert, 2003, Suppression of the malignant phenotype in human pancreatic cancer cells by the overexpression of manganese superoxide dimutase, Mol Cancer Ther, 2, 361 Cullen, 2003, The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma, Cancer Res, 63, 1297 Cullen, 2003, Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer, Pancreas, 26, 23, 10.1097/00006676-200301000-00005 Jaisawal, 2001, Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes, Gastroenterology, 120, 190, 10.1053/gast.2001.20875 Le Page, 2000, BRCA1 and BRCA2 are necessary for the transcription-coupled repari of the oxdidative 8-oxoguanine lesion in human cells, Cancer Res, 60, 5548 Wang, 2002, Inhibition of cancer cell growth by BRCA2, Cancer Res, 62, 1311 Handra-Luca, 2004, Correlation between patterns of DNA mismatch repair hmlh1 and hmsh2 protein expression and progression of dysplasia in intra-ductal papillary mucinous neoplasms of the pancreas, Virchows Archs, 444, 235, 10.1007/s00428-003-0966-0 Nio, 2001, Expression of Bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: effects on clinical outcome and efficacy of chemotherapy, J Surg Oncol, 76, 188, 10.1002/jso.1033 Maacke, 2000, DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma, Oncogene, 19, 2791, 10.1038/sj.onc.1203578 Bellacosa, 2001, Role of MED1 (MBD4) gene in DNA repair and human cancer, J Cell Physiol, 187, 137, 10.1002/jcp.1064 Wenger, 2001, Influence of antioxidative vitamins A, C and E on lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters, Prostaglandins Leukotrienes Essential Fatty Acids, 65, 165, 10.1054/plef.2001.0305 Wenger, 2001, Influence of octreotide on liver metastases and hepatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters, Pancreas, 23, 266, 10.1097/00006676-200110000-00007 Wenger, 2001, Effects of octreotide on liver metastasis and intrametastatic lipid peroxidation in experimental pancreatic cancer, Oncology, 60, 282, 10.1159/000055330 Majima, 1998, Inhibitory effects of betacarotene, palm carotene, and green polyphenols on pancreatic carcinogenesis initiated by N-nitrosobis(2-oxopropyl)amine in Syrian gold hamsters, Pancreas, 16, 13, 10.1097/00006676-199801000-00003 Wouterson, 1999, Modulation of pancreatic carcinogenesis by antioxidants, Food Chem Toxicol, 37, 981, 10.1016/S0278-6915(99)00093-9 Lynn-Cook, 1999, Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumour cells in vitro, Nutr Cancer, 35, 80, 10.1207/S1532791480-86 Takada, 2002, Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate, Pancreas, 25, 45, 10.1097/00006676-200207000-00012 Rautalahti, 1999, The effects of supplementation with alpha-to-copherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized controlled trial, Cancer, 86, 37, 10.1002/(SICI)1097-0142(19990701)86:1<37::AID-CNCR7>3.0.CO;2-F Zalatnai, 2003, Pancreatic cancer: a continuing challenge in oncology, Pathol Oncol Res, 9, 252, 10.1007/BF02893388